TY - JOUR T1 - <em>In vitro</em> nonalcoholic fatty liver disease model with cyclo-olefin-polymer-based microphysiological systems JF - bioRxiv DO - 10.1101/2020.12.28.424535 SP - 2020.12.28.424535 AU - Xiaopeng Wen AU - Makoto Yamanaka AU - Shiho Terada AU - Ken-ichiro Kamei Y1 - 2020/01/01 UR - http://biorxiv.org/content/early/2020/12/29/2020.12.28.424535.abstract N2 - Nonalcoholic fatty liver disease (NAFLD) is one of the common chronic liver conditions, whose treatment involves curing patients without liver transplantation. Understanding the mechanism of NAFLD initiation and progression would enable development of new diagnostic tools and drugs; however, until now, the underlying mechanisms of this condition remain largely unknown owing to the lack of experimental settings that can simplify the complicated NAFLD process in vitro. Microphysiological systems (MPSs) have long been used to recapture human pathophysiological conditions in vitro for applications in drug discovery. However, polydimethylsiloxane (PDMS) has been used in most of these MPSs as the structural material; it absorbs hydrophobic molecules, such as free fatty acids (FFAs), which are the key components that initiate NAFLD. Therefore, the current PDMS-based MPSs cannot be directly applied to in vitro NALFD modeling. In this work, we present an in vitro NAFLD model with an MPS made of cyclo-olefin polymer (COP), namely COP-MPS, to prevent absorption of FFAs. We demonstrated induction of the NAFLD-like phenotype in HepaRG hepatocyte-like cells cultured in the COP-MPS by introducing FFAs. The FFAs induced lipid accumulation in the HepaRG cells, resulting in inactivation of the apoptotic cells. We believe that the proposed COP-MPS can contribute toward investigations of NAFLD mechanisms and identification of new drugs to prevent the progression of liver disease and avoid liver transplantation.Competing Interest StatementM.Y. is an employee of Ushio Inc. A portion of this project was financially supported by Ushio Inc. The other authors declare no competing interests. ER -